Na, Y. M. | IICIMED

Na, Y. M.

Publications

P223

Pharmaceuticals. 2020, 13, 186.

Optimization, Antifungal Activity, Selectivity, and CYP51 Binding of New 2-Aryl-3-azolyl-1-indolyl-propan-2-ols.

Lebouvier, N. | Pagniez, F. | Na, Y. M. | Shi, D. | Pinson, P. | Marchivie, M. | Guillon, J. | Hakki, T. | Bernhardt, R. | Yee, S. W. | Simons, C. | Lézé, M.-P. | Hartmann, R. W. | Mularoni, A. | Le Baut, G. | Krimm, I. | Abagyan, R. | Le Pape, P. | Le Borgne, M. Synthesis,

doi:10.3390/ph13080186

P208

J. Enzym. Inhib. Med. Chem. 2020, 35, 398-403.

Biological exploration of a novel 1,2,4-triazole-indole hybrid molecule as antifungal agent.

Pagniez, F. | Lebouvier, N. | Na, Y. M. | Ourliac-Garnier, I. | Picot, C. | Le Borgne, M. | Le Pape, P.

doi: 10.1080/14756366.2019.1705292

Autres publications scientifiques

Brevets

Thèse

T02.

Azoles inhibiteurs de la 14α-déméthylase à activité antifongique et / ou antileishmanienne.

Na, Y. M.

Nantes, 22 septembre 2000.